LPL Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$281K Buy
+10,000
New +$266K ﹤0.01% 5229
2025
Q1
Sell
-150,200
Closed -$3.98M 5474
2024
Q4
$3.98M Sell
150,200
-133,600
-47% -$3.62M ﹤0.01% 2259
2024
Q3
$8.21M Buy
283,800
+243,800
+610% +$7.11M ﹤0.01% 1618
2024
Q2
$1.12M Buy
40,000
+38,276
+2,220% +$1.05M ﹤0.01% 3147
2024
Q1
$4.78M Sell
1,724
-27,076
-94% -$751K ﹤0.01% 1821
2023
Q4
$829K Sell
28,800
-16,300
-36% -$493K ﹤0.01% 3208
2023
Q3
$1.5M Buy
+45,100
New +$1.59M ﹤0.01% 2558
2020
Q1
Sell
-7,273
Closed -$270K 3375
2019
Q4
$270K Buy
+7,273
New +$259K ﹤0.01% 2864

Other funds holding PFE

LPL Financial's PFE Position: Q1 2026 in Review

LPL Financial increased its Pfizer (PFE) stake by 0.94% in Q1 2026, buying an estimated $3.31M and bringing the position to 13,393,661 shares worth $376M. The position accounts for 0.1% of the portfolio, ranked #206.

LPL Financial first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • LPL Financial held 13,393,661 shares of Pfizer worth $376M as of Q1 2026.
  • LPL Financial bought 124,181 Pfizer shares in Q1 2026, an estimated $3.31M.
  • Pfizer made up 0.1% of LPL Financial's portfolio in Q1 2026, its #206 holding.
  • LPL Financial first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.